PROTO SCRIPT PHARMACEUTICAL CORP Development Stage Entities, Equity Issuance, Per Share Amount (Deprecated 2015-01-31)
PROTO SCRIPT PHARMACEUTICAL CORP reported Development Stage Entities, Equity Issuance, Per Share Amount (Deprecated 2015-01-31) of $1 for the 12-month period ending 2013-05-31, per its 10-Q filed 2014-10-20.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EquityIssuancePerShareAmount · last filed 2014-10-20
- PROTO SCRIPT PHARMACEUTICAL CORP development stage entities, equity issuance, per share amount (deprecated 2015-01-31) for fiscal 2012 was $0.05, a 4900.00% increase from fiscal 2011.
- PROTO SCRIPT PHARMACEUTICAL CORP development stage entities, equity issuance, per share amount (deprecated 2015-01-31) for fiscal 2011 was $0.00.
USD
| Period end | Development Stage Entities, Equity Issuance, Per Share Amount (Deprecated 2015-01-31) 12 month |
|---|---|
| 2013-05-31 | $1.00 10-Q · filed 2014-10-20 |
| 2012-05-31 | $0.05 10-K · filed 2013-09-16 |
| 2011-05-31 | $0.00 10-K · filed 2013-09-16 |
USD/shares
| Period end | Development Stage Entities, Equity Issuance, Per Share Amount (Deprecated 2015-01-31) 12 month |
|---|---|
| 2013-05-31 | $1.00 10-Q · filed 2014-10-20 |